Miyazaki, Japan

Ena Akamatsu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Minami Nippon Dairy Co-Op Co., Ltd., Miyazaki Enterprise Promotion Organization, Miyazaki Prefecture. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ena Akamatsu. Retrieved from https://idiyas.com/inventor/ena-akamatsu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Inventor Ena Akamatsu: Pioneering Hepatitis C Research**

Introduction

Ena Akamatsu is a remarkable inventor based in Miyazaki, Japan, known for her significant contributions to medical research. With one patent to her name, she has made strides in the fight against hepatitis C, a viral infection that affects millions worldwide. Her innovative work and dedication highlight the importance of research in developing effective treatments.

Latest Patents

Akamatsu holds a patent for an "Agent for inhibiting production of hepatitis C virus and its use." This invention introduces a proanthocyanidin polymer composition that exhibits notable anti-HCV activity with minimal side effects. This advancement offers new hope for those affected by the virus, showcasing her commitment to improving public health.

Career Highlights

Throughout her career, Ena Akamatsu has been associated with the Miyazaki Enterprise Promotion Organization and Miyazaki Prefecture. These positions have provided her with the valuable experience and resources necessary to conduct her groundbreaking research. Her work has not only contributed to the scientific community but has also underscored the role of innovation in healthcare.

Collaborations

Akamatsu has collaborated with esteemed colleagues, including Masahiko Takeshita and Hirohito Tsubouchi. These partnerships have facilitated knowledge exchange and fostered innovative approaches to combating hepatitis C, enriching the research environment in which she operates.

Conclusion

Ena Akamatsu's contributions as an inventor emphasize the critical role of innovation in addressing complex health challenges. Her dedication to developing effective treatments for hepatitis C reflects her commitment to improving the lives of individuals affected by this disease. The impact of her work will resonate within the scientific community and beyond, as researchers continue to build on her pioneering findings.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…